{"id":8764,"date":"2021-01-13T14:06:46","date_gmt":"2021-01-13T14:06:46","guid":{"rendered":"https:\/\/www.innovationnewsnetwork.com\/?p=8764"},"modified":"2021-03-09T08:29:56","modified_gmt":"2021-03-09T08:29:56","slug":"proton-pump-inhibitors","status":"publish","type":"post","link":"https:\/\/www.innovationnewsnetwork.com\/proton-pump-inhibitors\/8764\/","title":{"rendered":"3D computer simulations identify how proton pump inhibitors can increase dementia risk"},"content":{"rendered":"
Millions of people use acid suppressants called proton pump inhibitors for conditions such as heartburn, gastritis, and stomach ulcers. Neurobiologists at Karolinska Institute have published in the journal Alzheimer’s & Dementia<\/em> <\/a>that proton pump inhibitors could be a potential factor in the development of dementia.<\/p>\n Proton pump inhibitors block the pumps that transport acidic hydrogen ions from the cells that form the mucosa. When the pump is disabled, there is a reduction in acid, minimising its damage to the tissue. Population studies have previously shown higher rates of dementia in people using this drug.<\/p>\n Taher Darreh-Shori, senior researcher at the Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, said: “We’ve been able to show that proton pump inhibitors affect the synthesis of the neurotransmitter acetylcholine, which plays a significant part in conditions such as Alzheimer’s disease. Since there is no effective treatment for the disease, it’s important to avoid risk factors. We therefore want to draw attention to this so that the drugs aren’t used needlessly for a long time.”<\/p>\nAnalysing the effect of proton pump inhibitors<\/h3>\n